메뉴 건너뛰기




Volumn 86, Issue 8, 1996, Pages 952-955

The effect of recombinant human erythropoietin on haematopoiesis in patients undergoing haemodialysis

Author keywords

[No Author keywords available]

Indexed keywords

ANTIANEMIC AGENT; ERYTHROCYTE CR 51; FERRIC CITRATE FE 59; HEMOGLOBIN; IRON; RECOMBINANT ERYTHROPOIETIN;

EID: 0029847659     PISSN: 02569574     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article
Times cited : (1)

References (27)
  • 2
    • 0022980521 scopus 로고
    • Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis
    • Winearls GC, Oliver DO, Pippard MJ, Reid C, Downing MR, Cotes PM. Effect of human erythropoietin derived from recombinant DNA on the anaemia of patients maintained by chronic haemodialysis. Lancet 1986; 2: 1175-1177.
    • (1986) Lancet , vol.2 , pp. 1175-1177
    • Winearls, G.C.1    Oliver, D.O.2    Pippard, M.J.3    Reid, C.4    Downing, M.R.5    Cotes, P.M.6
  • 3
    • 0023640448 scopus 로고
    • Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having haemodialysis
    • Casati S, Passerini P, Campise MR, et al. Benefits and risks of protracted treatment with human recombinant erythropoietin in patients having haemodialysis. BMJ 1987; 295: 1017-1020.
    • (1987) BMJ , vol.295 , pp. 1017-1020
    • Casati, S.1    Passerini, P.2    Campise, M.R.3
  • 4
    • 0023893502 scopus 로고
    • Erythropoietin: The developing story
    • Cotes PM. Erythropoietin: the developing story. BMJ 1988; 296: 805-806.
    • (1988) BMJ , vol.296 , pp. 805-806
    • Cotes, P.M.1
  • 5
    • 0023850473 scopus 로고
    • Recombinant human erythropoietin: Implications for nephrotogy
    • Eschbach JW, Adamson JW. Recombinant human erythropoietin: implications for nephrotogy. Am J Kidney Dis 1988; 11: 203-209.
    • (1988) Am J Kidney Dis , vol.11 , pp. 203-209
    • Eschbach, J.W.1    Adamson, J.W.2
  • 6
    • 0025374496 scopus 로고
    • Subcutaneous administration of recombinant human erythropoietin to subjects on continuous ambulatory peritoneal dialysis: An erythrokinetic assessment
    • Hughes RT, Cotes PM, Pippard MJ, et al. Subcutaneous administration of recombinant human erythropoietin to subjects on continuous ambulatory peritoneal dialysis: an erythrokinetic assessment. Br J Haematol 1990; 75: 268-273.
    • (1990) Br J Haematol , vol.75 , pp. 268-273
    • Hughes, R.T.1    Cotes, P.M.2    Pippard, M.J.3
  • 7
    • 0026495177 scopus 로고
    • RBC improved survival due to recombinant human erythropoietin explains effectiveness of less frequent, low dose subcutaneous therapy
    • Schwartz AB, Kahn SB, Kelch B, Kim KE, Pequignot E. RBC improved survival due to recombinant human erythropoietin explains effectiveness of less frequent, low dose subcutaneous therapy. Clin Nephrol 1992; 38: 283-289.
    • (1992) Clin Nephrol , vol.38 , pp. 283-289
    • Schwartz, A.B.1    Kahn, S.B.2    Kelch, B.3    Kim, K.E.4    Pequignot, E.5
  • 8
    • 0015335327 scopus 로고
    • On the in vivo action of erythropoietin: A quantitative analysis
    • Papayannopoulou T, Finch CA. On the in vivo action of erythropoietin: a quantitative analysis. J Clin Invest 1972; 51: 1179-1185.
    • (1972) J Clin Invest , vol.51 , pp. 1179-1185
    • Papayannopoulou, T.1    Finch, C.A.2
  • 9
    • 0020334281 scopus 로고
    • Erythropoiesis, erythropoietin and iron
    • Finch CA. Erythropoiesis, erythropoietin and iron. Blood 1982; 60: 1241-1246.
    • (1982) Blood , vol.60 , pp. 1241-1246
    • Finch, C.A.1
  • 10
    • 0025606734 scopus 로고
    • The treatment of renal anaemia in CAPD patients with recombinant human erythropoietin
    • Macdougall IC, Davies ME, Hutton RD, et al. The treatment of renal anaemia in CAPD patients with recombinant human erythropoietin. Nephrol Dial Transplant 1990; 5: 950-955.
    • (1990) Nephrol Dial Transplant , vol.5 , pp. 950-955
    • Macdougall, I.C.1    Davies, M.E.2    Hutton, R.D.3
  • 11
    • 0019314109 scopus 로고
    • Recommended methods for measurement of red-cell and plasma volume
    • International Committee for Standardization in Haematology. Recommended methods for measurement of red-cell and plasma volume. J Nucl Med 1980; 21: 793-800.
    • (1980) J Nucl Med , vol.21 , pp. 793-800
  • 12
    • 0019307542 scopus 로고
    • Recommended method for radioisotope red-cell survival studies
    • International Committee for Standardization in Haematology. Recommended method for radioisotope red-cell survival studies. Br J Haematol 1960; 45: 659-666.
    • (1960) Br J Haematol , vol.45 , pp. 659-666
  • 13
    • 34447488431 scopus 로고
    • The red cell chromium elution rate in patients with some hematologic diseases
    • Cline MJ, Berlin NI. The red cell chromium elution rate in patients with some hematologic diseases. Blood 1963; 21: 63-69.
    • (1963) Blood , vol.21 , pp. 63-69
    • Cline, M.J.1    Berlin, N.I.2
  • 15
    • 0006096685 scopus 로고
    • Ferrokinetic measurements
    • Cook JD, ed. New York: Churchill Livingstone
    • Cook JD, Finch CA. Ferrokinetic measurements. In: Cook JD, ed. Methods in Hematology Vol. I. Iron. New York: Churchill Livingstone, 1980: 134-147.
    • (1980) Methods in Hematology Vol. I. Iron , vol.1 , pp. 134-147
    • Cook, J.D.1    Finch, C.A.2
  • 17
    • 0025909869 scopus 로고
    • Rheological studies during treatment of renal anaemia with recombinant human erythropoietin
    • Macdougall IC, Davies ME, Hutton RD, Coles GA, Williams JD. Rheological studies during treatment of renal anaemia with recombinant human erythropoietin. Br J Haematol 1991; 77: 550-558.
    • (1991) Br J Haematol , vol.77 , pp. 550-558
    • Macdougall, I.C.1    Davies, M.E.2    Hutton, R.D.3    Coles, G.A.4    Williams, J.D.5
  • 19
    • 0026100490 scopus 로고
    • Echocardiographic findings in hemodialysis patients treated with recombinant human erythropoietin: Proposal for a hematocrit most beneficial to haemodynamics
    • Tagawa H, Nagano M, Saito H, Umezu M, Yamakado M. Echocardiographic findings in hemodialysis patients treated with recombinant human erythropoietin: proposal for a hematocrit most beneficial to haemodynamics. Clin Nephrol 1991; 35: 35-38.
    • (1991) Clin Nephrol , vol.35 , pp. 35-38
    • Tagawa, H.1    Nagano, M.2    Saito, H.3    Umezu, M.4    Yamakado, M.5
  • 21
    • 0025128680 scopus 로고
    • Erythropoietin, aluminium, and anaemia in patients on haemodialysis
    • Rosenlöf K, Fyhrquist F, Tenhunen R. Erythropoietin, aluminium, and anaemia in patients on haemodialysis. Lancet 1990; 335: 247-249.
    • (1990) Lancet , vol.335 , pp. 247-249
    • Rosenlöf, K.1    Fyhrquist, F.2    Tenhunen, R.3
  • 22
    • 34447487100 scopus 로고
    • The haematopoietic system in uraemia
    • Davison AM, ed. London: Bailliere Tindall
    • Eschbach JW. The haematopoietic system in uraemia. In: Davison AM, ed. Nephrology Vol. II. London: Bailliere Tindall, 1988: 1050-1056.
    • (1988) Nephrology Vol. II , vol.2 , pp. 1050-1056
    • Eschbach, J.W.1
  • 23
    • 0025010621 scopus 로고
    • Resistance to recombinant human erythropoietin in hemodialysis patients
    • Drueke TB. Resistance to recombinant human erythropoietin in hemodialysis patients. Am J Nephrol 1990; 10: 34-39.
    • (1990) Am J Nephrol , vol.10 , pp. 34-39
    • Drueke, T.B.1
  • 24
    • 0028908185 scopus 로고
    • Iron availability is transiently improved by intravenous iron medication in patients on chronic haemodialysis
    • Rosenlöf K, Kivivouri SM, Grönhagen-Riska C, Teppo AM, Slimes MA. Iron availability is transiently improved by intravenous iron medication in patients on chronic haemodialysis. Clin Nephrol 1995; 43: 249-255.
    • (1995) Clin Nephrol , vol.43 , pp. 249-255
    • Rosenlöf, K.1    Kivivouri, S.M.2    Grönhagen-Riska, C.3    Teppo, A.M.4    Slimes, M.A.5
  • 25
    • 0025829522 scopus 로고
    • Erythropoietin
    • Erslev AJ. Erythropoietin. N Engl J Med 1991; 324: 1339-1344.
    • (1991) N Engl J Med , vol.324 , pp. 1339-1344
    • Erslev, A.J.1
  • 26
    • 0025316398 scopus 로고
    • Renal function during erythropoietin therapy for anemia in predialysis chronic renal failure patients
    • Abraham PA, Opsahl JA, Rachael KM, Asinger R, Halstenson CE. Renal function during erythropoietin therapy for anemia in predialysis chronic renal failure patients. Am J Nephrol 1991; 10: 128-136.
    • (1991) Am J Nephrol , vol.10 , pp. 128-136
    • Abraham, P.A.1    Opsahl, J.A.2    Rachael, K.M.3    Asinger, R.4    Halstenson, C.E.5
  • 27
    • 0028121041 scopus 로고
    • Erythropoietin: The promise and the facts
    • Eschbach JW. Erythropoietin: The promise and the facts. Kidney Int 1994; 45: S70-S76.
    • (1994) Kidney Int , vol.45
    • Eschbach, J.W.1


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.